Inventages Venture Capital Investment Inc.
Venture Capital
Nassau, Bahamas
37
14M
25
1.68
17
0.32
2
- Stages of investment
- Areas of investment
Summary
In 2000 was created Inventages Venture Capital Investment Inc., which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main department of described VC is located in the London.
This organization was formed by Gunnar Weikert. The overall number of key employees were 2.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Inventages Venture Capital Investment Inc., startups are often financed by POSCO BioVentures, Seroba Life Sciences, Idinvest Partners. The meaningful sponsors for the fund in investment in the same round are Seroba Life Sciences, POSCO BioVentures, Enterprise Ireland. In the next rounds fund is usually obtained by BB Biotech Ventures, Ysios Capital, Roche Venture Fund.
Among the most successful fund investment fields, there are Manufacturing, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight AM Pharma, MSI Methylation Sciences, Opsona. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups.
Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Inventages Venture Capital Investment Inc. performs on 23 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2016. The top activity for fund was in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year.
Investor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 37
- Lead investments
- 17
- Exits
- 2
- Rounds per year
- 1.68
- Follow on index
- 0.32
- Investments by industry
- Biotechnology (25)
- Health Care (16)
- Therapeutics (11)
- Pharmaceutical (11)
- Medical (9) Show 25 more
- Investments by region
-
- United States (18)
- Germany (2)
- United Kingdom (6)
- Ireland (3)
- Canada (2) Show 3 more
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 160K
- Group Appearance index
- 0.65
- Avg. company exit year
- 9
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Accera | 16 Aug 2006 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 7M | United States, Colorado, Broomfield |
Heqi Juli Education Group | 25 Oct 2021 | Analytics, Career Planning, Higher Education, Big Data, Consulting | Early Stage Venture | Beijing, Beijing, China | |
MooBella | 12 Jul 2007 | Supply Chain Management, Manufacturing, Service Industry | Early Stage Venture | 25M | United States, Massachusetts, Taunton |
Similar funds
By same location




By same geo focus




By doing lead investments

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.